Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer

Introduction: To minimize the surgical morbidity after lymphadenectomy, sentinel node biopsy (SLNB) has become fundamental in the management of different malignancies. We decided to evaluate sentinel lymph node (SNL) biopsies also in patients with endometrial cancer undergoing hysterectomy with lymphadenectomy.

Methods: In the setting of a prospective study we developed a technique for sentinel node biopsy of ten patients with histologically confirmed endometrial cancer. Prior to surgery 99m Tc Nanocol was injected in the peritumoral region by hysteroscopy. Six hours later lymphoscintigraphy was performed to identify the draining lymph nodes. During surgery we first detected the sentinel lymph node by a hand-held gamma tracer and then removed it. Surgery was completed by the standard therapy of total hysterectomy, bilateral salpingo-oophorectomy and pelvic and/or para-aortic lymphadenectomy.

Results: Scintigraphic identification was possible in eight out of ten patients. Intraoperative identification of sentinel lymph nodes was possible in seven out of eight patients. In five patients we found the sentinel lymph nodes in the pelvic region while the other two patients had bilateral sentinel nodes in the pelvic and para-aortic region. Histologically confirmed microscopic tumor metastases of the SLNs and para-aortic lymph nodes were only found in one case. The sentinel lymph nodes from the other six patients were free of tumor and accurately reflected the pathological status.

Conclusion: The identification of sentinel lymph nodes in endometrial cancer is a practical and safe method. In order to improve this technique as a standard procedure for staging of endometrial cancer further studies with a larger number of patients have to be done.

Sentinel lymph node; Endometrial cancer; Lymphatic mapping; Lymphoscitigraphy

[1] Arbeitsgemeinschaft Bevolkerungsbezogener Krebsregister in Deutschland (ed.): "Krebs in Deutschland-Haufigkeiten und Trends". Statisches Landesamt Saarland. Saarbriicken, 1997.

[2] Schmidt-Matthiesen H., Bastert G., Wall wiener D.: "Gynakologische Onkologie 6”. Stuttgart, Auflage Schattauer, 2000

[3] AGO: "Leitlinie Endometriumkarzinom. Interdisziplinare kurz gefasste Leitlinie der Deutschen Krebsgeselschaft und der Deutschen geselschaft fiir Gynakologie und Geburtshilfe". Frauenarzt, 2000.

[4] Burke T., Eifel P., Muggia F.: "Cancer of the Uterine Body". In DeVita V., Hellmann S., Rosenberg S. (eds.), Cancer-Principles and Practice of Oncology. Philadelphia, J.B. Lippincott Co., 1997.

[5] Christorpherson W.: "The significance of pathologic findings in endometrial cancer". Clin. Obstet. Gynecol., 1986, 13, 673.

[6] Creasman W., Boronow R., Morrow P., DiSaia P., Blessing J.: "Adenocarcinoma of endometrium. Its metastatic lymph node potential. A preliminary report". Gynecol. Oncol., 1976, 4, 239.

[7] Creasman W., Morrow P., Bundy B., Hamesley H., Graham J., Heller P.: "Surgical Pathological Spread Patterns of Endometrial Cancer. A Gynecologic Oncology Group Study". Cancer, 1987, 60, 2035.

[8] Wallwiener D., Wagner U.: "Operative Therapie des Endometriumkarzinoms und seiner Prakanzerosen". Onkologe, 1999, 5, 403.

[9] Faught W., Krepart G., Lotoki R., Heywood M.: "Should selective paraaortic lymphadenectomy be a part of surgical staging for endometrial cancer?". Gynecol. Oncol., 1994, 55, 51.

[10] Morton D.L., Wen D., Wong J.H., Economus J.S., Cagle L.A., Storm F.K.: "Technical details of intaoperative lymphatic mapping for early stage of melanoma". Arch. Surg., 1992, 127, 392.

[11] Bilchik A.J., Giuliano A., Essner R., Bostik P., Kelemen P., Foshag L.J. et al.: "Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms" Cancer J. Sci. Am., 1998, 4, 351.

[12] Veronesi U., Paganelli G., Galimberti V., Viale G., Zurida S., Bedoni M. et al.: "Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes". Lancet, 1997, 343, 1864.

[13] Pitman KT., Johnson J.T, Edington H., Barnes E.L., Wagner R., Myers E.N.: "Lymphatic mapping with isolsulfan blue dye in squamous cell carcinoma of the head and neck". Arch. otolaryngo!. Head and Neck Surg., 1998, 124, 790.

[14] Konig M., Persis N., Franz H., Thelen M., Bares R., Kiesel L., Wallwiener D.: "Endoskopische Sentinel-Node (ESN)-Verfahren zum laparoskopisch assistierten Staging des Endometriumkarzinoms". Geburtsch Fraeunheilk, 2000, 60, 187.

[15] Albertini J.J., Lyman G.H., Cox C.E., Yetmann T., Balducci L., Ku N.N. et al.: "Lymphatic mapping and sentinel node biopsy in the patient with breast cancer". J. Am. Med. Assoc., 1996, 276, 1818.

[16] O'Boyle J.D, Coleman R.L., Bernstein S.G., Lifshitz S., Muller C.Y., Miller D.S.: "Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study" Gynecol. Oneal., 2000, 79, 238.

[17] Bass S.S., Cox C.E., Ku N.N., Berman C., Reintgen D.S.: "The role of sentinel lymph node biopsy in breast cancer". J. Am. Coll Surg., 1999, 189, 183.

[18] Pletl A, Friedman E.: "Lymphatic sytem of the female genitalia" In: Plentl A.F.E. (ed.), "Lymphatics of the Cervix Uteri". Philadelphia, Saunders, 1971, 2.

[19] Echt M. L., Finan M.A., Hoffmann M.S., Kline R.C., Roberts W.S, Fiorica J.V.: "Detection of sentinel lymph nodes with lymphazurin in cervical, uterine and vulvar malignicies". South Med. J., 1999, 92, 204.

[20] Levenback C., Burke T.W., Gershenson D.M., Morris M., Malpica A., Ross M.I.: "Intraoperative lymphatic mapping for vulvar cancer". Obstet. Gynecol., 1994, 84, 163.